Characteristics | s | Min | Q1 | Mdn. | Q3 | Max | Mean | SD |
---|---|---|---|---|---|---|---|---|
Mean age (years) | 18 | 20.1 | 30.8 | 39.3 | 49.4 | 63.1 | 39.85 | 12.9 |
Total Sample size at analysis | Â | Â | Â | Â | Â | Â | Â | Â |
− MBI group | 26 | 6.0 | 25.0 | 38.5 | 66.0 | 238.0 | 52.47 | 45.8 |
Control group | 26 | 6.0 | 22.0 | 31.0 | 61.0 | 260.0 | 48.98 | 51.3 |
Weeks of structured MBI | 22 | 2.0 | 5.0 | 8.0 | 8.0 | 14.0 | 7.07 | 3.3 |
Days across intervention (length) | 22 | 7.0 | 28.0 | 49.0 | 49.0 | 91.5 | 41.89 | 22.2 |
Structured MBI session/week | 23 | 0.50 | 1.0 | 1.0 | 7.0 | 14.0 | 3.77 | 3.9 |
Structured MBI min./session | 10 | 10.0 | 18.0 | 35.0 | 56.3 | 90.0 | 40.0 | 29.1 |
Dose (length x duration) | 9 | 280.0 | 609.0 | 980.0 | 2712.0 | 4410.0 | 1607.0 | 1421.5 |
Days after intervention measured | 26 | 0.0 | 0.0 | 0.0 | 91.5 | 183.0 | 47.98 | 70.7 |
% Attrition, MBI group | 25 | 0.0 | 7.9 | 15.0 | 37.5 | 79.4 | 23.06 | 18.4 |
% Attrition, Control group | 25 | 0.0 | 5.0 | 15.4 | 26.2 | 45.5 | 16.93 | 13.9 |